PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29301250-4	2018	By simultaneously interacting with the alphaD region (new allosteric site) and sub-ATP binding pocket, the attractive compound CAM4066 was named as allosteric inhibitor of CK2alpha.	CAM4066	127-134	casein kinase 2 alpha 2	Homo sapiens	172-180	
29732088-4	2018	Whilst CAM4066 bound to this new pocket it was also interacting with the ATP site: herein, we describe an example of a CK2alpha inhibitor that binds completely outside the active site.	CAM4066	7-14	casein kinase 2 alpha 2	Homo sapiens	119-127	
29301250-6	2018	The molecular dynamics simulations and energy analysis revealed that the appropriate coupling between the linker and pharmacophore fragments were essential for binding of CAM4066 with CK2alpha.	CAM4066	171-178	casein kinase 2 alpha 2	Homo sapiens	184-192	
28495381-1	2017	Recently we reported the discovery of a potent and selective CK2alpha inhibitor CAM4066.	CAM4066	80-87	casein kinase 2 alpha 2	Homo sapiens	61-69	
28451126-4	2016	An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2alpha with a Kd of 320 nM and shows significantly improved selectivity compared to other CK2alpha inhibitors.	CAM4066	157-164	casein kinase 2 alpha 2	Homo sapiens	177-185	
28451126-4	2016	An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2alpha with a Kd of 320 nM and shows significantly improved selectivity compared to other CK2alpha inhibitors.	CAM4066	157-164	casein kinase 2 alpha 2	Homo sapiens	269-277